AtaiBeckley Inc. [ATAI] - Eli Lilly / AtaiBeckley merger

Eli Lilly's wholly owned subsidiary, Albali Acquisition Corporation, will acquire AtaiBeckley for $6.75 in cash per share, plus one contingent value right potentially worth up to $2.50, representing a 40% premium to AtaiBeckley's 30-day volume-weighted average price as of July 15, 2026.

View source filing ↗